Go to content
UR Home

Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study

URN to cite this document:
DOI to cite this document:
Schneider, Markus P. ; Schmid, Matthias ; Nadal, Jennifer ; Krane, Vera ; Saritas, Turgay ; Busch, Martin ; Schultheiss, Ulla T. ; Meiselbach, Heike ; Friedrich, Nele ; Nauck, Matthias ; Floege, Jürgen ; Kronenberg, Florian ; Wanner, Christoph ; Eckardt, Kai-Uwe ; Oefner, Peter J. ; Gronwald, Wolfram
Date of publication of this fulltext: 08 Apr 2024 07:08


Copeptin and Midrange pro-atrial natriuretic peptide (MR-pro-ANP) are associated with outcomes independently of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in patients with heart failure (HF). The value of these markers in patients with chronic kidney disease (CKD) has not been studied.

Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons